Current status of prophylaxis against rheumatic fever (Q40997127)

25 September 2017

title

Current status of prophylaxis against rheumatic fever (English)

1 reference

25 September 2017

0 references

FEINSTEIN AR

1

1 reference

25 September 2017

publication date

1 November 1960

1 reference

Progress in Cardiovascular Diseases

25 September 2017

published in

1 reference

25 September 2017

volume

3

1 reference

25 September 2017

page(s)

204-219

1 reference

Nature of rheumatic fever

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Prevention of rheumatic fever by prompt penicillin therapy of hemolytic streptococcic respiratory infections; progress report

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

A controlled study of three methods of prophylaxis against streptococcal infection in a population of rheumatic children. I. Streptococcal infections and recurrences of acute rheumatic fever in the first two years of the study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

A controlled study of three methods of prophylaxis against streptococcal infection in a population of rheumatic children. II. Results of the first three years of the study, including methods for evaluating the maintenance of oral prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Prevention of rheumatic fever and rheumatic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Prophylaxis of rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

The use of antibiotics for the prevention of rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

The prevention of rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Prevention of rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Prophylaxis of rheumatic fever and rheumatic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

A controlled study of beta hemolytic streptococcal infection in rheumatic families. I. Streptococcal disease among healthy siblings

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Rôle of beta-Hemolytic Streptococci in Common Respiratory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

The accuracy of diagnosis of beta streptococcal infections on clinical grounds

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Prevention of rheumatic fever recurrences

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Recent developments in the prevention of rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

The effect of penicillin prophylaxis on streptococcal disease rates and the carrier state

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Prevention of rheumatic fever by treatment of previous streptococcic infections; effect of sulfadiazine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Oral Penicillin Prophylaxis of Streptococcal Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Benzathine penicillin G: its effectiveness in the prevention of streptococcal infections in a heavily exposed population

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Streptococcal infection in a school population: preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

A study of streptococcal infection in a school population: laboratory methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Community control of rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

The Casper project-an enforced mass-culture streptococcic control program

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Some basic, unsolved problems in the prevention of rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Correlation of smoking habits with hemolytic streptococci and antistretolysin O responses

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Treatment of beta hemolytic streptococcic infections in the home; relative value of available methods

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Studies on the prevention of rheumatic fever; the effect of time of initiation of treatment of streptococcal infections on the immune response of the host

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

The role of the streptococcus in the pathogenesis of rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Comparison of the Recurrence Rate of Rheumatic Carditis among Children Receiving Penicillin by Mouth Prophylactically or on Indication

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Short-term hormone therapy; its effect in active rheumatic carditis of varying duration

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Relationship of immune response to group A streptococci to the course of acute, chronic and recurrent rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

The paradox of the antibody response to streptodornase: the usefulness of antidesoxyribonuclease B as an indication of streptococcal infection in patients with acute rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

A controlled study of beta hemolytic streptococcal infection in rheumatic families. II. Penicillin prophylaxis among rheumatic fever subjects, comparing different regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Prophylaxis against group A streptococcal infections in rheumatic fever patients; use of new repository penicillin preparation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Untoward reactions to benzathine penicillin G in a study of rheumatic-fever prophylaxis in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

The prophylaxis of streptococcal infections in patients with rheumatic fever; a comparison between sulfadiazine and erythromycin.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Aureomycin in the prophylaxis of rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Use of sulfamethoxypyridazine in the prevention of streptococcal infections in rheumatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

The use of weekly oral doses of sulfamethoxypyridazine for rheumatic fever prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Prevention of secondary attacks of rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Rheumatic fever in the adult: criteria and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

Staining bacterial smears with fluorescent antibody. IV. Grouping streptococci with fluorescent antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2860%2980008-4

7 January 2021

10.1016/S0033-0620(60)80008-4

Identifiers

DOI

1 reference

release_5qsxqebppzf6plqhrc566ti4pe

25 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5qsxqebppzf6plqhrc566ti4pe

24 November 2022

mapped directly with Wikidata item

1 reference